Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07347886

Clinical Outcomes of Sedation in Cataract Surgery Performed Under Topical Anesthesia

This study aims to evaluate the clinical outcomes of different sedation strategies in patients undergoing cataract surgery performed under topical anesthesia. Cataract surgery is commonly performed under topical anesthesia; however, some patients may experience anxiety, discomfort, or inadequate cooperation during the procedure. Sedation may improve patient comfort and surgical conditions, but it may also be associated with potential adverse effects.

In this randomized, prospective study, patients will be assigned to one of three groups: topical anesthesia alone, topical anesthesia combined with midazolam, or topical anesthesia combined with midazolam and fentanyl. Intraoperative sedation levels, hemodynamic parameters, patient satisfaction, and surgeon satisfaction will be assessed and compared among the groups.

The results of this study are expected to provide evidence regarding the effectiveness and safety of sedation during cataract surgery performed under topical anesthesia and to help optimize perioperative sedation strategies for these patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

Istanbul, Turkey (Türkiye)

Location contact

Bekzat Emilbekov, Anesthesiology resident

CONTACT

[email protected]

+90 544 586 14 33

About this study

Cataract surgery is one of the most frequently performed ophthalmologic procedures and is commonly carried out under topical anesthesia. Although topical anesthesia provides adequate analgesia, some patients may experience anxiety, discomfort, or difficulty in maintaining cooperation during the procedure. Sedation is frequently used as an adjunct to topical anesthesia to improve patient comfort and surgical conditions; however, concerns remain regarding potential respiratory and hemodynamic adverse effects, particularly in elderly patients.

This prospective, randomized clinical study is designed to evaluate the clinical outcomes of different sedation strategies in patients undergoing cataract surgery performed under topical anesthesia. Adult patients scheduled for elective cataract surgery will be randomly assigned to one of three groups. Group 1 will receive topical anesthesia alone without sedation. Group 2 will receive topical anesthesia combined with intravenous midazolam. Group 3 will receive topical anesthesia combined with intravenous midazolam and fentanyl. Randomization will be performed using a predefined allocation method to ensure balanced group distribution.

All patients will be monitored using standard intraoperative monitoring, including non-invasive blood pressure, electrocardiography, and peripheral oxygen saturation. Supplemental oxygen will be administered when clinically indicated. Sedative agents will be administered according to standardized dosing protocols. Intraoperative sedation depth will be assessed using a validated sedation scale, and hemodynamic and respiratory parameters will be recorded throughout the procedure.

The primary outcome of the study is postoperative patient satisfaction, which will be assessed using the Iowa Satisfaction with Anesthesia Scale - Turkish version (ISAS-T). Secondary outcomes include intraoperative sedation level, surgeon satisfaction, hemodynamic stability, respiratory events, additional sedative requirements, and the occurrence of sedation-related adverse effects. Surgeon satisfaction will be evaluated using a standardized Likert-type scale.

The results of this study are expected to provide evidence regarding the impact of different sedation strategies on patient satisfaction and overall clinical outcomes in cataract surgery performed under topical anesthesia. These findings may contribute to optimizing perioperative sedation practices and improving patient-centered care in ophthalmic anesthesia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 50 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Patients scheduled for elective unilateral cataract surgery
  • Surgery planned to be performed under topical anesthesia
  • Ability to understand the study procedures and provide written informed consent after being fully informed about the study

Exclusion criteria

  • Refusal to participate in the study or withdrawal of consent at any stage of the study
  • Known intolerance or contraindication to sedative and/or opioid medications
  • Presence of significant cardiac arrhythmias
  • Severe chronic obstructive pulmonary disease (COPD)
  • Hepatic or renal failure
  • Inability to cooperate due to cognitive impairment or hearing disability
  • Opioid dependence
  • Diagnosis of obstructive sleep apnea syndrome (OSAS)
  • New York Heart Association (NYHA) class III-IV heart failure
  • Conversion to general anesthesia for any reason during surgery

Treatment and study plan

normal saline

Drug

Intravenous normal saline administered in an identical volume as placebo to maintain blinding. No sedative or opioid medication will be given.

Other names: Pacebo

Midalozam

Drug

Intravenous midazolam administered for procedural sedation during cataract surgery performed under topical anesthesia. The medication will be prepared and administered in standardized doses and identical volumes to maintain blinding.

Other names: Dormicum

Fentanyl (IV)

Drug

intravenous fentanyl administered in combination with midazolam to provide analgesia and sedation during cataract surgery under topical anesthesia. The medication will be prepared and administered in standardized doses and equal volumes to ensure blinding across study groups.

Other names: Fentanyl citrtate

Primary outcomes

  1. Patient satisfaction after cataract surgery

    Time frame: 1 hour postoperatively

    Patient satisfaction will be assessed using the validated Turkish version of the Iowa Satisfaction with Anesthesia Scale (ISAS-T). The ISAS-T total score will be calculated according to the instrument instructions; higher scores indicate greater satisfaction.

Secondary outcomes

  1. Intraoperative sedation level

    Time frame: During surgery (intraoperative period

    Intraoperative sedation depth will be assessed using the Ramsay Sedation Scale during cataract surgery performed under topical anesthesia.

  2. Preoperative anxiety level

    Time frame: Preoperative period (before surgery)

    Preoperative anxiety will be assessed using the Turkish version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS).

  3. Surgeon satisfaction

    Time frame: Immediately after surgery

    Surgeon satisfaction will be assessed using a 5-point Likert scale.

  4. İntraoperative heart rate

    Time frame: During surgery

    Heart rate will be continuously monitored intraoperatively using standard anesthesia monitoring.

    Values will be recorded at predefined time points during surgery.

  5. İntraoperative mean arterial pressure

    Time frame: During surgery

    Mean arterial pressure will be measured intraoperatively using non-invasive blood pressure monitoring.

    Measurements will be recorded at predefined time points during surgery.

  6. Respiratory events

    Time frame: During surgery

    Intraoperative respiratory events will be assessed using continuous pulse oximetry (SpO₂ monitoring) and clinical airway intervention records.

    Oxygen desaturation will be defined as SpO₂ < 90% lasting ≥ 10 seconds.

    Airway support will be recorded as the need for any of the following interventions: jaw thrust, chin lift, insertion of an oral or nasal airway, or assisted ventilation via face mask.

    Each event will be recorded as a binary outcome (yes/no) during the intraoperative period.

Study contacts

Contact information is provided by the study sponsor or research team.

Bekzat Emilbekov, Anesthesiology resident

CONTACT

[email protected]

+90 544 586 14 33

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Acronym: SADCAT

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 16, 2026
Registry last updated
Jan 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.